Howard G. Rosenthal, MD

Professional Background

As a practicing Orthopedic Oncologist for 30 years, I have devoted my career to the treatment of patients with bone and soft tissue sarcomas. Orthopedic Oncology a very young and new specialty and I have had the privilege and honor of being involved with it from essentially its inception. I have been involved with the development of tumor prostheses, from the early days of custom designed implants, to the development of an entire limb reconstruction modular system that can be available for a patient at any time. Non-invasive limb lengthening techniques have enabled us to salvage even the youngest patient's limbs with preservation of limb lengths even into adulthood, and my involvement in the development of these types of implants have improved the practice of numerous other orthopedic oncologists, trauma surgeons, and of course patients. Our continued research, both on the basic science level as well as clinical sphere have improved our care of patients with sarcoma.

• MD, Orthopedics, University of Arizona College of Medicine, Tucson, AZ
• Internship, General Surgery, University of Kansas Medical Center, Kansas City, KS
• Post Doctoral Fellowship, Orthopedic Oncology and Metabolic Bone Disease, Memorial Sloan-Kettering Cancer Center Hospital for Special Surgery, New York, NY
• Clinical Fellowship, Mulculoskeletal Oncology, Rizzoli Orthopedic Institute, Bologna, Italy
• Clinical Fellowship, Musculoskeletal Oncology, Ilizarov Fellowship, Lecco, Italy, Lecco, Italy

• Medical Licensure, Kansas State Board of Healing Arts
• Medical Licensure, Missouri State Board of Registration for the Healing Arts

• American Cancer Society Cancer Action Network, Member, 2013 - Present
• Sarcoma Alliance for Research through Collaboration, Member, 2013 - Present
• The University of Kanas Health System, Indian Creek Governing Board, Member, 2013 - Present
• The University of Kanas Health System, Melanoma/Sarcoma DWG, Chair, 2013 - Present
• The University of Kanas Health System, Osteosarcoma Working Group, Chair, 2013 - Present
• The University of Kanas Health System, Surgical Oncology Committee, Member, 2013 - Present
• The University of Kanas Health System, Surgical Services Committee, Member, 2013 - Present

---

Research

Overview

As Medical Director of the Sarcoma Center at Kansas University Health Systems, a nationally recognized team has been created serving patients with Sarcoma. Our research team, clinical trials involvement, and Sarcoma Tumor Board with outcomes measurement, enable our program to excel and improve.

• SMITH, C, ZHANG, D, HOOVER, L, ROSENTHAL, H., G, TAWFIK, O., W. 2019. Primary osseous anyliodoma - Report of two cases with review of literature. Journal of Modern Human Pathology
• Pessetto, Z., Y, Chen, B, Alturkmani, H, Hyter, S, Flynn, C., A, Baltezor, M, Ma, Y, Rosenthal, H., G, Neville, K., A, Weir, S., J, Butte, A., J, Godwin, A., K. 2017. In silico and in vitro drug screening identifies new therapeutic approaches for Ewing sarcoma.. Oncotarget, 8 (3), 4079-4095
• Pessetto, Z., Y, Chen, B, Alturkmani, H, Hyter, S, Flynn, C., A, Baltezor, M, Ma, Y, Rosenthal, H., G, Neville, K., A, Weir, S., J, Butte, A., J, Godwin, A., K. 2017. In silico and in vitro drug screening identifies new therapeutic approaches for Ewing sarcoma.. Oncotarget, 8 (3), 4079-4095
• Pessetto, Z., Y, Chen, B, Alturkmani, H, Hyter, S, Flynn, C., A, Baltezor, M, Ma, Y, Rosenthal, H., G, Neville, K., A, Weir, S., J, Butte, A., J, Godwin, A., K. 2017. In silico and in vitro drug screening identifies new therapeutic approaches for Ewing sarcoma.. Oncotarget, 8 (3), 4079-4095
• Schultzel, M., M, Johnson, M., H, Rosenthal, H., G. 2014. Bilateral deltoid myositis ossificans in a weightlifter using anabolic steroids.. Orthopedics, 37 (9), e844-7